75 results about "Drug allergy" patented technology

The invention relates to food, in particular to Food for improving the constitutional trait and a preparation technology of the food. According to the food for improving the constitutional trait, synergy is achieved by efficacy of medicines through reasonable compatibility, so that the food has the functions of improving symptoms such as poor season and climate adaptability, easiness of scratch on skin, proneness to forming of wheal and urticaria, proneness to hay fever, asthma and the like, proneness to trigger of inveterate disease, drug allergy, food allergy and the like for allergic constitution.

The invention discloses quantitative determination and drug allergy determination kits for helicobacter pylori viable bacteria and a determination method. The method adopts viable helicobacter pylori as a sample to be detected; the property that the viable helicobacter pylori can generate urease is used for rapidly and accurately reading the quantity of the helicobacter pylori by a helicobacter pylori colony counting standard method (CFU / ml, namely the bacterium individual quantity in each ml of bacterium liquid and a colony quantity standard curve); the detection result is accurate and sensitive and has high reliability; the counting difficulty of existing helicobacter pylori clinic microbiological identification, caused by difficult culture and complicated operation, is solved; the drug allergy determination kit and a preparation method, which are expanded by the invention, can be used for carrying out various drug allergy tests at the same time; clinicians can rapidly and conveniently screen suitable anti-helicobacter pylori medicines so that the time and the labor are saved and the cost is saved, so as to provide a beneficial technical solution for clinical scientific treatment.

The invention discloses a system for visually identifying and analyzing as well as identifying drug allergy. The system comprises an optical and digital image acquiring device, a digital image processing device and a drug allergy identifying and analyzing device, wherein the optical and digital image acquiring device is used for providing a light source and acquiring the digital image, and sending the digital image to the digital image processing device; a polarizer and an analyzer in the optical and digital image acquiring device are used for strengthening the digital image of the detected object, and the cubic aberration of the digital image is corrected through a lens; the digital image processing device is used for receiving the digital image, capturing motion, performing filtration and feature enhancement on the image after sensing a target code, determining a target specimen type according to target specimen characteristics and bar code information after obtaining the target specimen image, selecting a detecting method to obtain detected results, processing and sending the detected results to the drug allergy identifying and analyzing device; the drug allergy identifying and analyzing device is used for identifying drug allergy by combining a mode identifying algorithm with preset CLIS (cost-of-living index) identifying standards in the drug allergy identifying and analyzing device, and obtaining the identifying conclusions.

The invention relates to a method used for extracting an antibacterial composition from limulus reagent production waste materials. The method comprises following steps: 1, raw material treatment is carried out, wherein a lower layer precipitate waste material obtained in centrifugation of an emulsified product in limulus reagent production is collected, and is taken as a raw material I, and discarded blood plasma in limulus reagent production is collected, and is taken as a raw material II; 2, extraction of a tachyplesin crude extracted solution is carried out, wherein acidolysis is carried out, pH is adjusted so as to remove a precipitate product, and thermal denaturation is carried out; 3, preparation of a hemocyanin crude extracted solution from blood plasma is carried out; 4, preparation of a SOD crude extracted solution is carried out; 5, 60 to 80 parts of the tachyplesin crude extracted solution,10 to 20 parts of the hemocyanin crude extracted solution, and 10 to 20 parts of the SOD crude extracted solution are mixed, pH value is adjusted to 4 to 5, and filtering is carried out so as to obtain the antibacterial composition. According to the method, the crude extracted solutions are prepared rapidly and conveniently at low cost; the antibacterial composition is capable of inhibiting growth of a plurality of kinds of bacteria and fungus; compared with conventional chemical antibacterial products, the antibacterial composition possesses following advantages: the antibacterial composition is safe, mild, and effective, no toxic or side effect is caused, and generation of drug resistance and drug allergy caused by conventional antibacterial products can be avoided.

The invention discloses a medical composition for treating mucosa infection and wound infection and auxiliarily treating a breast cancer, which is prepared from following raw materials based on the mass percentage: 35-45% of lantana camara, 15-25% of bidens biternata, 15-25% of clerodendrum fortunatum and 15-25% of radix astragali. The medical composition for treating the mucosa infection and the wound infection and auxiliarily treating the breast cancer disclosed by the invention can rapidly and effectively cure various mucosa infection, drug allergy and wound infection of human bodies, poultries and domestic animals, and is effective in treatment; and scars are not formed on wounds of patients and the medical composition has no side effects. The medical composition for treating the mucosa infection and the wound infection and auxiliarily treating the breast cancer disclosed by the invention has good treating effect on auxiliarily treating the breast cancer and is effective in treatment.

Methods of assessing the risk of clinical signs of hypersensitivity reaction to nucleoside antiviral compounds, including abacavir, are described. The methods include genotyping subjects for polymorphisms in the TNFα gene, the class 1 HLA genes, or a combination of both the TNFα and HLA genes.

The invention discloses a method for distinguishing ureaplasma urealyticum and ureaplasma parvum in ureaplasma by using a culture method. The method comprises the following steps: firstly, confirmingtwo detection micro-pores, namely a pore A and a pore B; putting a proper amount of glucose or / and a urease inhibitor into the pore A, putting a manganese-magnesium solution into the pore B, drying, adhering the glucose or / and the urease inhibitor to the inner wall of the pore A, and adhering manganese ions and magnesium ions to the inner wall of the pore A; putting a sample to be tested into a ureaplasma culture medium, uniformly mixing, respectively putting into the pore A and the pore B, and culturing for 24-48 hours at 37 DEG C; and according to the color change situations of the pore A and the pore B, confirming whether the sample has ureaplasma urealyticum and ureaplasma parvum or not. A kit which is relatively convenient to use is prepared according to the method. The method disclosed by the invention is simple to operate, whether a specimen contains the ureaplasma urealyticum and the ureaplasma parvum or not can be precisely distinguished at one step, meanwhile, the method canbe implemented together with drug allergy detection, and identification and drug allergy results can be achieved; and identification results are visible and accurate, and clinical popularization and application are facilitated.

The invention relates to the technical field of drug allergy detection and further discloses a drug allergy detection device for cancer patients. A base is included. A mounting plate is fixedly connected to the upper end of the base, a conical gear ring is fixedly connected to the left side of the mounting plate, a supporting plate is fixedly connected to the right side of the mounting plate, a motor is fixedly connected to the upper end of the supporting plate, a rotating shaft is fixedly connected to an output end of the motor, and a U-shaped rod is fixedly connected to the end, away from the motor, of the rotating shaft. According to the drug allergy detection device for cancer patients, the U-shaped rod drives a connecting column to synchronously rotate so as to drive a detection testtube to synchronously rotate; a bevel gear is matched to revolve around an axis of the bevel gear ring and autoroatation is generated at the same time; and a first transmission wheel is indirectly driven to synchronously rotate so that the detection test tube is driven to synchronously rotate through the connecting column, and the detection test tube rotates around the axis of the rotating shaft and the axis of the connecting column at the same time so that effects of more uniform medicament mixing and high result reliability are achieved.